Here's an article that answers your question [1]. It in the second bullet point near the top.
[1] https://trial.medpath.com/news/5c43f09ebb6d0f8e/ozempic-show...
[1] https://trial.medpath.com/news/5c43f09ebb6d0f8e/ozempic-show...
After adjustment for sex, BMI, hsCRP, and sCD163, semaglutide significantly decreased epigenetic aging: PCGrimAge (-3.1 years, P = 0.007), GrimAge V1 (-1.4 years, P = 0.02), GrimAge V2 (-2.3 years, P = 0.009), PhenoAge (-4.9 years, P = 0.004), and DunedinPACE (-0.09 units, ≈9 % slower pace, P = 0.01). Semaglutide also lowered the multi-omic OMICmAge clock (-2.2 years, P = 0.009) and the transposable element-focused RetroAge clock (-2.2 years, P = 0.030).